Thermo Fisher Scientific Announces Application Deadlines for Life Sciences Scholarships
News Nov 14, 2012
Thermo Fisher Scientific Inc. announced the Winter/Spring semester application deadline for its Thermo Scientific Pierce Scholarship program, which provides educational opportunities and $80,000 in scholarships annually to the future generation of scientists. Winter/Spring semester applications are being accepted through December 14, 2012. Applications and scholarship award criteria can be found at https://www.pierce-antibodies.com/PierceScholarship.
The Thermo Scientific Pierce Scholarship program, awarded for Summer/Fall and Winter/Spring academic semesters, is open to graduate and undergraduate students studying biology, chemistry, biochemistry or a related life science field. Applicants are required to demonstrate strong academic skills along with how their passion for science transcends the lab.
“We’ve been extremely impressed with the high caliber of applicants we’ve seen so far,” said Jeff Lee, commercial director for immunoassay products, Thermo Fisher Scientific. “The Thermo Scientific Pierce Scholarship invests in future scientists and we anticipate that many of these winners will soon be driving new discoveries and making a positive impact on the community.”
The 2012-2013 Winter/Spring Semester scholarship awards include two $10,000 scholarships and four $5,000 scholarships. To qualify, a student must have a GPA of 3.0 or higher (on a 4.0 scale); be enrolled in a graduate or undergraduate program at an accredited college or university for the 2012-2013 Winter/Spring semester; and be a legal U.S resident. Scholarship recipients will be notified in January 2013.
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Comments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.Cancer Research Cell Science Drug Discovery Genomics Research Informatics & Automation Proteomics & Metabolomics
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE